Dec 5, 2023

Vasu Chandrasekaran, VP of real-world data and analytics at Ontada, provides an electronic health record platform, iKnowMed, used by community oncology providers to practice evidence-based and patient-centered medicine better.  They also work closely with the US Oncology Network to improve access to new therapies and clinical trials. Using real-world data to generate real-world evidence allows Ontada, in partnership with biopharma companies, to drive drug discovery and development, conduct more diverse trials, and better understand the effectiveness of treatments.

Vasu explains, "Community oncology is where most of the cancer care happens. We enable those physicians in the community to practice evidence-based and patient-centered medicine through our EHR platform. Our clinical decision support system and other workflows built into the EHR platform enable physicians to practice oncology and deliver precise care to patients in the community. That's the first thing I would say. That's one of the offerings."

"And secondly, because we are part of McKesson, we have a very close partnership with The US Oncology Network, which is the largest network of community oncology practices. We can work very closely with the physicians in The Network to understand what is working well for them in the technology and what needs to be improved. This close partnership enables us to be agile and make changes to the technology that reflects the standard of care."

"Lastly, on the life sciences side, we work with biopharma companies and use real-world data coming from the routine care delivery, the data about the patient’s health status, demographics, diagnoses, testing, treatments, etc. We use that to generate real-world evidence that can be used to help understand the real-world effectiveness of treatments, and that can be used to help accelerate new therapies to patients." 

#Ontada #RealWorldData #Oncology #Cancer #CancerCare #DrugDevelopment

ontada.com

Listen to the podcast here